Successful Liver Transplantation From a SARS-CoV-2 Positive Donor to a Positive Recipient: Potential Role of Monoclonal Antibodies

Transplantation. 2022 Mar 1;106(3):e181-e182. doi: 10.1097/TP.0000000000004032.

Authors

Zachary A Yetmar¹, Nischal Ranganath¹, Robert C Huebert^{2

3}, Charles B Rosen^{3

4}, Raymund R Razonable^{1

3}, Elena Beam^{1

3}

Affiliations

¹ Division of Infectious Diseases, Mayo Clinic, Rochester, MN.
² Divison of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN.
³ William J. von Liebig Center for Transplantation and Clinical Regeneration, Mayo Clinic, Rochester, MN.
⁴ Division of Transplantation Surgery, Mayo Clinic, Rochester, MN.

No abstract available

MeSH terms

Antibodies, Monoclonal / therapeutic use
Antibodies, Viral
COVID-19*
Humans
Liver Transplantation* / adverse effects
SARS-CoV-2
Tissue Donors

Substances

Antibodies, Monoclonal
Antibodies, Viral